Photo of: Michael Ewer

Dr. Michael S. Ewer

View Title...

University of Texas M. D. Anderson Cancer Center , Houston
Michael's profile was created using:
Sort By:

1-10 of 11 online sources for Michael Ewer

  • View Online Source
    old.imeronline.com/319_bc/home.html - [Cached Version]
    Published on: 8/1/2008    Last Visited: 7/3/2009  

    Michael S. Ewer, MD University of Texas M. D. Anderson Cancer Center
    ...
    Dr. Ewer is a professor of medicine at the University of Texas M. D. Anderson Cancer Center, Houston. He received his doctor of medicine from the University of Basel Medical Faculty, Switzerland, and received his doctor of jurisprudence from the University of Houston Law Center. His special interests include cardiotoxicity of anticancer treatments, medical ethics, and patients' rights. He has written more than 200 publications and lectures frequently throughout the United States, Europe, and Asia.

    Michael Ewer, MD, reported a financial interest/relationship of affiliation in the form of: Consultant, Roche Laboratories, Inc., sanofi-aventis U.S., and Genentech BioOncology; Speakers' Bureaus, Roche Laboratories, Inc., sanofi-aventis U.S., and Genentech BioOncology..

  • View Online Source
    www.cancernetwork.com/breast-cancer/article/10165/13892 - [Cached Version]
    Published on: 11/1/2008    Last Visited: 3/26/2009  

    MICHAEL S. EWER, MD Professor of Medicine The University of Texas

  • View Online Source
    www.imeronline.com/319_bc/home.html - [Cached Version]
    Published on: 8/1/2008    Last Visited: 12/9/2008  

    Michael S. Ewer, MD University of Texas M. D. Anderson Cancer Center
    ...
    Dr. Ewer is a professor of medicine at the University of Texas M. D. Anderson Cancer Center, Houston. He received his doctor of medicine from the University of Basel Medical Faculty, Switzerland, and received his doctor of jurisprudence from the University of Houston Law Center. His special interests include cardiotoxicity of anticancer treatments, medical ethics, and patients' rights. He has written more than 200 publications and lectures frequently throughout the United States, Europe, and Asia.

    Michael Ewer, MD, reported a financial interest/relationship of affiliation in the form of: Consultant, Roche Laboratories, Inc., sanofi-aventis U.S., and Genentech BioOncology; Speakers' Bureaus, Roche Laboratories, Inc., sanofi-aventis U.S., and Genentech BioOncology..

    Anthracyclines and HER2 Inhibitors: Benefits vs. Risks

  • View Online Source
    www.imeronline.com/2008_congress/319.html - [Cached Version]
    Published on: 1/1/2008    Last Visited: 4/30/2008  

    Michael S. Ewer, MD
    ...
    Michael S. Ewer, MDUniversity of Texas M.D.Anderson Cancer Center
    ...
    Presenters: Michael S. Ewer, MDUniversity of Texas MD Anderson Cancer Center
    ...
    Presenters: Michael S. Ewer, MD

  • View Online Source
    ADVANCE For Nurse Practitioners Online | Past Online... - [Cached Version]
    Published on: 6/21/2001    Last Visited: 6/21/2001  

    It is unusual , agreed Michael Ewer , MD , associate professor of chemistry at MD Anderson Cancer Center , Houston.Ewer is an oncologic cardiologist whose primary focus is the often serious impact cancer in general can have on the heart's ability to function , particularly through the means used to treat cancer.

    Mechanical DifficultiesBoth providers agreed that imaging , especially echocardiography , is key to diagnosis before the heart is damaged beyond repair.Determining the presence of a cancerous growth is particularly important because cardiac tumors are frequently asymptomatic until they cause mechanical problems.

    These include :.

    ...
    Without an image to reveal its presence , many of the symptoms of a malignant tumor can look more like coronary artery disease , Dr. Ewer said.In fact , cardiac cancer is often discovered only when the patient is undergoing diagnostic imaging for another condition.

    Perhaps [ the patient ] was taking phen-fen and got a cardiac ultrasound to test for valve damage , and a totally asymptomatic mass was noted in the heart.This certainly is something that can happen , he offered.

    Echocardiography is the primary tool used to image both for cardiac tumors and for possible reduction of heart function due to cancer treatment.
    ...
    Dr. Ewer said breast metastases are found more often simply because there are more instances of breast cancer.
    ...
    It doesn't attack the heart muscle in the way a tumor would invade it , explained Dr. Ewer.It causes a change on the cellular level that causes destruction of individual myocytes ( heart muscle cells ).As more and more of these heart muscle cells are destroyed , you have varying degrees of heart contractility ( ability to pump ) ..

    Cardiac toxicity is cumulative.After a point , he added , the heart can no longer compensate.Nevertheless , many patients do recover , he noted , in that they adjust to a lower cardiac function.
    ...
    Dr. Ewer explained that chemotherapy has to be directed at the kind of cancer present.The risks of treatment must also be weighed against the risks of no treatment.

    ...
    In addition to the estimated 10 percent of cancer patients who develop cardiac problems , Dr. Ewer pointed out , there is also another group to be considered : those who have underlying heart disease before getting cancer.

    For these patients , the cancer may place added stress on their limited cardiac reserves , he noted.Someone with ischemic cardiac disease or a history of myocardial infarctions is likely to suffer less oxygen-carrying capacity if their hemoglobin levels drop because of their cancer or its treatment.

    They have problems with their heart that they wouldn't have gotten into if they hadn't also had a malignancy , he said , describing the interaction of the two diseases as conspiring..

    Dr. Ewer added that when heart disease and other medical problems combine , the diagnoses of cardiac conditions , such as heart attacks and congestive heart failure , are more difficult to place in perspective , since the various symptoms of the conditions can overlap and reinforce each other.

    Image interpretation must become much more detailed and clinically biased because , with multiple conditions affecting the body , he said , sometimes things can fool you..

  • View Online Source
    ADVANCE For Nurse Practitioners Online | Past Online... - [Cached Version]
    Published on: 6/16/2001    Last Visited: 6/16/2001  

    It is unusual , agreed Michael Ewer , MD , associate professor of chemistry at MD Anderson Cancer Center , Houston.Ewer is an oncologic cardiologist whose primary focus is the often serious impact cancer in general can have on the heart's ability to function , particularly through the means used to treat cancer.

    Mechanical DifficultiesBoth providers agreed that imaging , especially echocardiography , is key to diagnosis before the heart is damaged beyond repair.Determining the presence of a cancerous growth is particularly important because cardiac tumors are frequently asymptomatic until they cause mechanical problems.

    These include :.

    ...
    Without an image to reveal its presence , many of the symptoms of a malignant tumor can look more like coronary artery disease , Dr. Ewer said.In fact , cardiac cancer is often discovered only when the patient is undergoing diagnostic imaging for another condition.

    Perhaps [ the patient ] was taking phen-fen and got a cardiac ultrasound to test for valve damage , and a totally asymptomatic mass was noted in the heart.This certainly is something that can happen , he offered.

    Echocardiography is the primary tool used to image both for cardiac tumors and for possible reduction of heart function due to cancer treatment.
    ...
    Dr. Ewer said breast metastases are found more often simply because there are more instances of breast cancer.Moreover , melanoma is by far the more dangerous , added Dr. Taub , because unlike breast and lung metastases , which wrap around the heart , melanoma can infiltrate the heart muscle itself , interfering with physical pumping and with conduction.

    Cancer Treatment Can Affect the HeartWhere cardiac tumors , both primary and metastasized , cannot be treated surgically , other modalities must be employed --- with caution.Both radiation therapy and chemotherapy can themselves cause significant damage to the heart.Indeed , radiation therapy of the heart is avoided whenever possible.
    ...
    It doesn't attack the heart muscle in the way a tumor would invade it , explained Dr. Ewer.It causes a change on the cellular level that causes destruction of individual myocytes ( heart muscle cells ).As more and more of these heart muscle cells are destroyed , you have varying degrees of heart contractility ( ability to pump ) ..

    Cardiac toxicity is cumulative.After a point , he added , the heart can no longer compensate.Nevertheless , many patients do recover , he noted , in that they adjust to a lower cardiac function.
    ...
    Dr. Ewer explained that chemotherapy has to be directed at the kind of cancer present.The risks of treatment must also be weighed against the risks of no treatment.

    ...
    In addition to the estimated 10 percent of cancer patients who develop cardiac problems , Dr. Ewer pointed out , there is also another group to be considered : those who have underlying heart disease before getting cancer.

    For these patients , the cancer may place added stress on their limited cardiac reserves , he noted.Someone with ischemic cardiac disease or a history of myocardial infarctions is likely to suffer less oxygen-carrying capacity if their hemoglobin levels drop because of their cancer or its treatment.

    They have problems with their heart that they wouldn't have gotten into if they hadn't also had a malignancy , he said , describing the interaction of the two diseases as conspiring..

    Dr. Ewer added that when heart disease and other medical problems combine , the diagnoses of cardiac conditions , such as heart attacks and congestive heart failure , are more difficult to place in perspective , since the various symptoms of the conditions can overlap and reinforce each other.

    Image interpretation must become much more detailed and clinically biased because , with multiple conditions affecting the body , he said , sometimes things can fool you..

  • View Online Source
    AccessMedicine | Contributors: Hurst's The Heart, 12e - [Cached Version]
    Published on: 11/2/2007    Last Visited: 10/3/2009  

    Michael S. Ewer, MD, JD, MPH, LLM Professor of Medicine The University of Texas M.D. Anderson Cancer Center

  • View Online Source
    Editorial Advisory Board | Internal Medicine World... - [Cached Version]
    Published on: 7/31/2008    Last Visited: 10/6/2009  

    Michael S. Ewer, MD, JD Professor of Medicine Department of Cardiology M.D. Anderson Cancer Center

  • View Online Source
    Healthscout Articles - [Cached Version]
    Published on: 9/6/2002    Last Visited: 5/20/2003  

    "What this paper has demonstrated is that while we thought we had a pretty good idea of exactly what the risks are of doxorubicin, we have to be a little more cautious" in using it, says study co-author Dr. Michael Ewer, a heart expert at the University of Texas' M.D.Anderson Cancer Center."If you have signs of decreasing function then you do need to stop the drug right away, but that's usually a little later than you wished you would have stopped it."

    A report on the findings appears in the June 1 issue of Cancer.The work was funded by Pharmacia, which makes a version of doxorubicin called Adriamycin.

    Ewer's group, led by Dr. Sandra Swain of the National Cancer Institute, reviewed three earlier studies of doxorubicin, also known as Rubex, and heart failure in patients with lung and breast cancer.
    ...
    In addition to the greater prevalence of heart problems, Ewer's group noted two other areas of concern with the cancer drug.People over age 65 were about 20 percent more likely than younger patients to suffer the complication.And a heart output test doctors have been using to monitor heart function in people taking doxorubicin doesn't seem to be of much use.Some patients with no problems have abnormal test results, while others with failing pumps go undetected."It's just an imperfect test," Ewer says.
    ...
    SOURCES: Michael Ewer, M.D., professor, cardiology, M.D.Anderson Cancer Center, Houston; June 1, 2003, Cancer

Page:  1 2 Next

Wrong Person?

Try these instead
Related searches
More...

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-11-09_RC001.1 OM14